Flow cytometry and immunofluorescence analysis indicated that sphere-derived cells from cell lines contained a much larger proportion of cells expressing CD44, a candidate surface marker of breast cancer stem cells, and/or a smaller proportion of cells expressing the non-stem cell marker CD24, compared with adherent cells (Figure 4A). This evidence concerns the gene CD44 and breast carcinoma.